MedTrace Logo

Validation of Proteomic Analyses for Allergic Asthma and Rhinitis

NCT01104012 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2015-03-27

No results posted yet for this study

Summary

The purpose of this study is to verify and validate the intrinsic diagnostic value in terms of sensitivity and specificity of proteomic profiles determined during a pre-study for discriminating between allergy related asthma and allergy related rhinitis.

Conditions

  • Rhinitis, Allergic
  • Asthma, Allergic

Interventions

BIOLOGICAL

Classification as "asthmatic" or "rhinitis only" via proteomic analysis

Proteomic profiles are established for each patient using plasma and serum samples

BIOLOGICAL

Classification as "asthmatic" or "rhinitis only" according to a metacholine test

A positive metacholine test indicating bronchial hyperresponsiveness is currently our Gold Standard for diagnosing asthma.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Nicolas Molinari, PhD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01104012 on ClinicalTrials.gov